03Aug
KidneyIntelX in Multi-Center Study to Monitor and Predict Kidney Risk in COVID-19 Patients
Surge in Chronic Kidney Disease and Kidney Failure Expected Post-COVID-19
Mount Sinai-Led Study to Assess 4,000 Surviving COVID-19 Patients.. Read More →
31Jul
Total Voting Rights
As of 31 July 2020, the Company's issued and fully paid share capital consists of 72,029,634 ordinary shares with a nominal value of £0.0025 each,.. Read More →